Myriam Curet Sells 230 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 230 shares of the company’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $532.61, for a total transaction of $122,500.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Myriam Curet also recently made the following trade(s):

• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The stock was sold at an average price of $559.90, for a total value of $58,229.60.
• On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $560.00, for a total value of $58,800.00.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $3.00 during trading hours on Wednesday, reaching $522.04. 1,850,622 shares of the stock were exchanged, compared to its average volume of 2,102,794. The firm has a market capitalization of $187.14 billion, a price-to-earnings ratio of 66.16, a P/E/G ratio of 4.12 and a beta of 1.67. The stock’s fifty day simple moving average is $561.53 and its 200 day simple moving average is $511.67. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a report on Friday, January 9th. HSBC raised their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday. Barclays set a $712.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday. BTIG Research reaffirmed a “buy” rating and issued a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Citigroup reaffirmed a “neutral” rating and set a $590.00 price objective (down previously from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $620.41.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA cleared the da Vinci 5 for select advanced cardiac procedures, expanding Intuitive’s addressable market in minimally invasive heart surgery — a potential medium?term revenue catalyst. ISRG’s da Vinci Gets FDA Nod for Advanced Cardiac Procedures
• Positive Sentiment: TD Cowen initiated/upgraded coverage to a strong?buy / buy stance, providing a fresh bullish analyst view that can support investor confidence. TD Cowen initiates coverage of Intuitive Surgical (ISRG) with buy recommendation
• Positive Sentiment: HSBC published a bullish forecast calling for strong price appreciation, and Barclays reiterated a buy — additional institutional analyst support that may offset short?term weakness. HSBC Forecasts Strong Price Appreciation for Intuitive Surgical Barclays Remains a Buy on Intuitive Surgical (ISRG)
• Positive Sentiment: Polen Capital highlighted ISRG as a position for future growth in its Q4 letter, indicating continued institutional interest from growth managers. Polen Capital Bets on Robotic Surgery Leader Intuitive Surgical (ISRG)
• Neutral Sentiment: Market commentary questioned whether it’s time to reassess ISRG after recent share?price weakness — useful context for momentum traders but not a direct company action. Is It Time To Reassess Intuitive Surgical (ISRG) After Recent Share Price Weakness?
• Negative Sentiment: Director Gary S. Guthart sold a large block of shares (reported filings show major sales on Jan. 27 totaling millions of dollars), which can be interpreted negatively by the market as signaling reduced insider conviction or tax/liquidity actions. SEC Filing — Gary S. Guthart
• Negative Sentiment: EVP Myriam Curet disclosed a smaller sale (230 shares), adding to the day’s insider sell narrative although impact is small relative to Guthart’s trades. SEC Filing — Myriam Curet

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Brighton Jones LLC grew its holdings in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC boosted its position in Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the period. Kathmere Capital Management LLC bought a new stake in Intuitive Surgical during the 2nd quarter worth approximately $203,000. Avior Wealth Management LLC increased its position in Intuitive Surgical by 29.0% in the 2nd quarter. Avior Wealth Management LLC now owns 1,700 shares of the medical equipment provider’s stock valued at $924,000 after acquiring an additional 382 shares during the period. Finally, Independence Bank of Kentucky raised its stake in shares of Intuitive Surgical by 18.8% during the second quarter. Independence Bank of Kentucky now owns 1,133 shares of the medical equipment provider’s stock valued at $616,000 after acquiring an additional 179 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.